Home > Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC)

Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC)

Table Published: February 14, 2011

This table displays the annual support level for various research, condition, and disease categories based on grants, contracts, and other funding mechanisms used across the National Institutes of Health (NIH).

At the request of Congress, the NIH embarked on a process to provide better consistency and transparency in the reporting of its funded research. This new process, implemented in 2008 through the Research, Condition, and Disease Categorization (RCDC) system, uses sophisticated text data mining (categorizing and clustering using words and multiword phrases) in conjunction with NIH-wide definitions used to match projects to categories. The definitions are a list of terms and concepts selected by NIH scientific experts to define a research category. The research category levels represent the NIH’s best estimates based on the category definitions.

The NIH does not expressly budget by category. The annual estimates reflect amounts that change as a result of science, actual research projects funded, and the NIH budget. The research categories are not mutually exclusive. Individual research projects can be included in multiple categories so amounts depicted within each column of this table do not add up to 100 percent of NIH-funded research.

Consistent with the Administration’s emphasis on transparency, two separate columns are used to distinguish FY 2009 and FY 2010 actual support funded from American Recovery & Reinvestment Act (ARRA) accounts from projects funded by regular NIH appropriations.

The FY2007 data were produced from a reporting process historically used by NIH. The technical elements of the previous reporting process did not have the ability to produce uniform results and led to wide variability in the way research categories were coded. This process caused inconsistencies in reporting data. RCDC use of data mining improves the consistency and eliminates the wide variability in defining the research categories reported. The table shows historical data for FY2007 and data produced with the new RCDC methodology for FY2007 through FY2010. The FY 2011-2012 estimates are based on RCDC actual data.

Total Number of Research/Disease Areas: 229
Table data as of March 15, 2011
Click here for instructions on how to use the data table below.

Research/Disease Areas (Dollars in millions and rounded)	FY 2007 Actual NIH Historical Method 10/	FY 2007 Actual NIH Revised Method 10/	FY 2008 Actual	FY 2009 Actual (Non-ARRA)	FY 2009 Actual (ARRA) 11/	FY 2010 Actual (Non-ARRA)	FY 2010 Actual (ARRA) 11/	FY 2011 Estimated	FY 2012 Estimated
Acute Respiratory Distress Syndrome	$48	$87	$82	$103	$17	$110	$22	$110	$112
Adolescent Sexual Activity	-	**	N/A	N/A	N/A	$80	$7	$80	$81
Agent Orange & Dioxin	$18	$15	$13	$13	$2	$11	$1	$11	$11
Aging	$2,462	$1,879	$1,965	$3,015	$554	$2,517	$443	$2,517	$2,562
Alcoholism	$521	$443	$452	$441	$75	$454	$65	$454	$461
Allergic Rhinitis (Hay Fever)	$5	$7	$6	$4	$1	$3	$1	$3	$3
ALS	$39	$40	$43	$43	$13	$47	$12	$47	$47
Alzheimer's Disease	$645	$411	$412	$457	$77	$450	$79	$450	$458
American Indians / Alaska Natives	$141	$159	$142	$169	$19	$151	$16	$150	$154
Anorexia	$12	$8	$7	$8	$2	$9	$2	$9	$9
Anthrax	$105	$160	$134	$102	$13	$118	$12	$118	$121
Antimicrobial Resistance	$269	$209	$228	$251	$52	$356	$66	$350	$358
Aphasia	$14	$20	$22	$22	$3	$21	$1	$21	$21
Arctic	$19	$25	$22	$28	$6	$34	$3	$34	$34
Arthritis	$339	$222	$232	$246	$65	$249	$59	$249	$253
Assistive Technology	$184	$192	$215	$249	$43	$250	$48	$250	$254
Asthma	$294	$252	$246	$284	$51	$244	$33	$244	$248
Ataxia Telangiectasia	$11	$14	$13	$13	$2	$12	$1	$12	$12
Atherosclerosis	$347	$468	$460	$495	$112	$544	$104	$544	$553
Attention Deficit Disorder (ADD)	$107	$61	$60	$71	$13	$66	$15	$66	$68
Autism	$127	$93	$118	$132	$64	$160	$58	$160	$163
Autoimmune Disease	$587	$759	$762	$879	$138	$856	$125	$855	$869
Basic Behavioral and Social Science	$1,104	$1,119	$1,149	$1,410	$206	$1,163	$198	$1,163	$1,184
Batten Disease	$8	$5	$5	$5	$2	$5	$1	$5	$5
Behavioral and Social Science	$3,060	$3,157	$3,215	$3,471	$582	$3,526	$603	$3,525	$3,590
Biodefense 1/	$1,735	$1,735	$1,736	$1,755	$213	$1,794	$221	$1,549	$1,853
Bioengineering	$1,469	$2,610	$2,853	$3,155	$569	$3,166	$760	$3,162	$3,225
Biotechnology	$9,814	$5,344	$5,179	$5,619	$1,051	$5,682	$1,203	$5,675	$5,808
Brain Cancer	$193	$204	$194	$234	$42	$274	$36	$274	$279
Brain Disorders	$4,670	$3,592	$3,729	$3,538	$685	$3,847	$619	$3,845	$3,915
Breast Cancer	$707	$729	$726	$722	$111	$763	$61	$763	$778
Burden of Illness	$524	$60	$48	$43	$11	$48	$8	$48	$49
Cancer	$5,643	$5,549	$5,570	$5,629	$1,120	$5,823	$803	$5,823	$5,934
Cardiovascular	$2,370	$1,942	$2,027	$2,008	$396	$2,144	$398	$2,143	$2,180
Cerebral Palsy	$16	$30	$28	$21	$4	$19	$3	$19	$19
Cervical Cancer	$96	$67	$69	$84	$15	$93	$8	$93	$95
Charcot-Marie-Tooth Disease	$7	$9	$12	$14	$2	$15	$1	$15	$16
Child Abuse and Neglect Research	$38	$41	$30	$32	$5	$32	$5	$32	$33
Childhood Leukemia	$55	$50	$39	$47	$12	$55	$12	$54	$55
Chronic Fatigue Syndrome (ME/CFS)	$4	$4	$4	$5	$0	$6	$0	$6	$6
Chronic Liver Disease and Cirrhosis	$379	$253	$241	$274	$37	$284	$45	$284	$289
Chronic Obstructive Pulmonary Disease	$91	$72	$75	$96	$18	$118	$15	$118	$120
Climate Change	$47	$4	$4	$4	$2	$4	$2	$4	$5
Clinical Research	$9,116	$9,862	$9,629	$10,336	$1,854	$10,720	$1,540	$10,707	$10,908
Clinical Trials	$2,949	$3,422	$3,562	$2,966	$485	$3,286	$356	$3,282	$3,343
Colo-Rectal Cancer	$282	$273	$274	$281	$48	$291	$26	$291	$297
Comparative Effectiveness Research	-	**	+	$194	$246	$558	$320	$558	$568
Complementary and Alternative Medicine	$299	$426	$430	$513	$70	$521	$55	$521	$531
Conditions affecting unborn children	$110	$81	$81	$95	$8	$98	$21	$98	$99
Contraception/Reproduction	$314	$460	$473	$427	$65	$419	$56	$419	$426
Cooley's Anemia	$34	$22	$22	$21	$3	$20	$3	$20	$20
Cost Effectiveness Research	$155	$50	$49	$52	$16	$80	$14	$80	$82
Crohn's Disease	$69	$47	$51	$55	$14	$66	$12	$66	$68
Cystic Fibrosis	$82	$78	$90	$86	$13	$86	$13	$86	$88
Dental/Oral and Craniofacial Disease	$417	$484	$463	$490	$75	$497	$67	$497	$506
Depression	$345	$398	$402	$402	$48	$420	$50	$420	$428
Diabetes 2/	$1,037	$1,069	$1,080	$1,030	$121	$1,046	$153	$1,044	$1,060
Diagnostic Radiology	$694	$1,046	$1,095	$976	$206	$1,073	$280	$1,072	$1,091
Diethylstilbestrol (DES)	$6	$5	$4	$4	$1	$4	$1	$4	$4
Digestive Diseases	$1,234	$1,460	$1,426	$1,538	$243	$1,657	$228	$1,656	$1,687
Digestive Diseases - (Gallbladder)	$6	$6	$7	$7	$1	$5	$0	$5	$5
Digestive Diseases - (Peptic Ulcer)	$23	$15	$14	$17	$3	$30	$3	$30	$30
Down Syndrome	$16	$16	$17	$18	$4	$22	$6	$22	$22
Drug Abuse (NIDA Only) 3/ 13/	$1,001	$1,001	$1,007	$1,040	$135	$1,067	$125	$1,059	$1,080
Duchenne/ Becker Muscular Dystrophy	$23	$23	$22	$27	$6	$33	$5	$33	$34
Dystonia	$16	$18	$15	$16	$2	$14	$1	$14	$14
Eating Disorders 4/	-	**	+	$26	$5	$28	$4	$28	$29
Emerging Infectious Diseases	$1,816	$1,733	$2,098	$2,080	$307	$2,118	$350	$2,117	$2,161
Emphysema	$21	$30	$29	$28	$11	$23	$9	$23	$23
Endometriosis	$12	$12	$15	$15	$2	$15	$1	$15	$15
Epilepsy	$105	$145	$145	$128	$21	$134	$27	$134	$137
Estrogen	$164	$283	$245	$235	$34	$231	$23	$231	$235
Eye Disease And Disorders Of Vision	$714	$800	$796	$862	$129	$817	$110	$817	$831
Facioscapulohumeral Muscular Dystrophy	$4	$3	$3	$3	$2	$5	$1	$5	$5
Fetal Alcohol Syndrome	$34	$32	$34	$34	$7	$33	$5	$33	$34
Fibroid Tumors (Uterine)	$14	$20	$16	$18	$2	$12	$2	$12	$12
Fibromyalgia	$9	$11	$12	$11	$2	$9	$0	$9	$9
Food Safety	$278	$230	$244	$262	$37	$290	$35	$290	$295
Fragile X Syndrome	$27	$22	$26	$27	$5	$25	$4	$25	$26
Frontotemporal Dementia (FTD)	$31	$17	$17	$22	$2	$18	$1	$18	$19
Gene Therapy	$325	$250	$249	$221	$28	$248	$32	$248	$252
Gene Therapy Clinical Trials	$31	$12	$16	$11	$0	$14	$0	$14	$14
Genetic Testing	$395	$402	$383	$316	$76	$298	$121	$298	$304
Genetics	$4,878	$7,000	$6,872	$7,278	$1,676	$7,473	$1,440	$7,470	$7,614
Global Warming Climate Change	$56	$1	$1	$3	$1	$2	$2	$2	$2
Headaches	-	**	N/A	N/A	N/A	$18	$1	$18	$18
Health Disparities 5/	$2,744	$2,744	$2,614	$2,806	$434	$2,728	$351	$2,726	$2,777
Health Effects of Climate Change	$164	$258	$286	$179	$35	$188	$23	$188	$191
Health Services	$1,023	$730	$743	$1,102	$316	$1,143	$334	$1,142	$1,185
Heart Disease	$2,126	$1,126	$1,217	$1,202	$227	$1,329	$235	$1,328	$1,352
Heart Disease - Coronary Heart Disease	$382	$379	$367	$426	$98	$457	$80	$457	$465
Hematology	$1,128	$881	$894	$908	$151	$961	$141	$961	$978
Hepatitis	$174	$176	$180	$178	$23	$204	$25	$204	$208
Hepatitis - A	$2	$6	$6	$4	$0	$4	$0	$4	$4
Hepatitis - B	$42	$53	$53	$51	$6	$66	$4	$66	$67
Hepatitis - C	$108	$100	$93	$97	$12	$100	$12	$100	$102
HIV/AIDS 6/ 12/	$2,906	$2,906	$2,928	$3,019	$319	$3,085	$322	$3,086	$3,160
Hodgkin's Disease	$17	$12	$16	$26	$1	$24	$1	$24	$25
Homelessness	$18	$14	$13	$16	$3	$15	$3	$15	$16
Homicide and Legal Interventions	$8	$1	*	$2	$1	$1	$0	$1	$1
HPV and/or Cervical Cancer Vaccines	$20	$16	$19	$25	$2	$25	$2	$25	$25
Human Fetal Tissue 7/	$19	**	$40	$41	$22	$55	$24	$55	$56
Human Genome	$1,099	$1,246	$1,259	$1,775	$566	$1,904	$598	$1,903	$1,939
Huntington's Disease	$53	$49	$51	$57	$12	$65	$7	$65	$66
Hyperbaric Oxygen	$2	$3	$4	$3	$0	$2	$0	$2	$2
Hypertension	$390	$231	$263	$266	$41	$251	$50	$251	$255
Immunization	$1,342	$1,713	$1,734	$1,773	$191	$1,798	$231	$1,798	$1,835
Infant Mortality/ (LBW)	$464	$227	$246	$246	$32	$273	$53	$273	$278
Infectious Diseases	$3,059	$3,433	$3,575	$3,627	$526	$3,890	$568	$3,888	$3,968
Infertility	$51	$65	$73	$75	$17	$76	$16	$75	$77
Inflammatory Bowel Disease	$80	$74	$81	$91	$22	$106	$19	$106	$108
Influenza	$271	$280	$204	$316	$46	$308	$88	$308	$315
Injury - Childhood Injuries	$27	$28	$26	$33	$3	$36	$3	$36	$36
Injury - Trauma - (Head and Spine)	$219	$164	$150	$161	$33	$179	$31	$178	$182
Injury - Traumatic brain injury	$82	$73	$59	$71	$15	$85	$9	$85	$86
Injury - Unintentional Childhood Injury	$21	$17	$15	$19	$1	$22	$1	$22	$22
Injury (total) Accidents/Adverse Effects	$403	$299	$299	$340	$58	$372	$46	$372	$379
Interstitial Cystitis	$23	$10	$10	$11	$1	$12	$1	$12	$12
Kidney Disease	$450	$531	$523	$570	$85	$552	$98	$552	$561
Lead Poisoning	$15	$13	$9	$11	$3	$11	$1	$11	$12
Liver Cancer	$90	$103	$89	$94	$12	$102	$10	$102	$104
Liver Disease	$423	$589	$562	$572	$79	$627	$85	$627	$639
Lung	$1,013	$1,169	$1,211	$1,265	$234	$1,269	$207	$1,269	$1,292
Lung Cancer	$249	$164	$169	$178	$36	$201	$22	$201	$205
Lupus	$84	$113	$126	$115	$19	$112	$15	$112	$114
Lyme Disease	$22	$26	$22	$25	$5	$24	$5	$24	$25
Lymphoma	$158	$186	$193	$184	$22	$195	$14	$195	$199
Macular Degeneration	$70	$135	$135	$85	$8	$104	$9	$104	$106
Malaria	$104	$112	$132	$110	$11	$134	$14	$134	$136
Malaria Vaccine	$36	$31	$32	$34	$3	$41	$4	$41	$42
Mental Health	$1,853	$2,061	$2,086	$2,129	$382	$2,246	$334	$2,246	$2,287
Mental Retardation (Intellectual and Developmental Disabilities (IDD))	$204	$305	$350	$281	$94	$311	$87	$311	$317
Methamphetamine	$45	$66	$67	$69	$13	$73	$14	$73	$74
Migraines	-	**	N/A	N/A	N/A	$15	$0	$15	$15
Mind and Body	$133	$571	$567	$494	$90	$549	$81	$548	$558
Minority Health 5/	$2,407	$2,407	$2,396	$2,592	$378	$2,526	$312	$2,525	$2,572
Mucopolysaccharidoses (MPS)	$10	$8	$7	$7	$0	$8	$0	$8	$8
Multiple Sclerosis	$98	$149	$169	$137	$25	$133	$18	$133	$135
Muscular Dystrophy	$47	$58	$56	$66	$17	$74	$12	$74	$75
Myasthenia Gravis	$6	$10	$9	$9	$3	$8	$3	$8	$8
Myotonic Dystrophy	$8	$9	$9	$9	$4	$10	$2	$10	$10
Nanotechnology 8/	$215	$257	$304	$343	$73	$435	$76	$435	$443
Networking and Information Technology R&D; 8/	$507	$959	$911	$1,174	$168	$647	$248	$646	$663
Neurodegenerative	$1,166	$1,579	$1,621	$1,553	$262	$1,571	$243	$1,571	$1,599
Neurofibromatosis	$13	$12	$14	$17	$2	$24	$1	$24	$24
Neuropathy	$59	$118	$121	$119	$13	$121	$10	$121	$123
Neurosciences	$4,809	$5,102	$5,224	$5,320	$848	$5,515	$794	$5,513	$5,612
Nutrition	$1,075	$1,327	$1,391	$1,400	$205	$1,435	$208	$1,434	$1,460
Obesity	$661	$595	$664	$745	$117	$824	$147	$823	$837
Organ Transplantation	$358	$187	$175	$139	$32	$150	$37	$150	$153
Orphan Drug	$1,158	$653	$645	$441	$118	$512	$89	$512	$522
Osteogenesis Imperfecta	$5	$8	$5	$5	$1	$8	$4	$8	$8
Osteoporosis	$164	$167	$183	$198	$21	$181	$23	$181	$184
Otitis Media	$15	$20	$18	$15	$7	$19	$2	$19	$20
Ovarian Cancer	$103	$89	$96	$102	$13	$122	$10	$122	$125
Paget's Disease	$4	$1	$1	$1	$1	$1	$0	$1	$1
Pain Conditions - Chronic	$224	$277	$279	$333	$53	$360	$44	$360	$366
Parkinson's Disease	$187	$143	$152	$162	$24	$154	$18	$154	$157
Patient Safety	-	**	N/A	N/A	N/A	$859	$263	$858	$875
Pediatric	$3,173	$2,622	$2,771	$2,996	$505	$3,286	$479	$3,282	$3,341
Pediatric AIDS 6/	$262	$262	$241	$227	$20	$216	$15	$216	$220
Pediatric Research Initiative	$171	**	$209	$214	$256	$308	$148	$307	$312
Pelvic Inflammatory Disease	$3	$4	$3	$3	$1	$4	$1	$4	$4
Perinatal - Birth - Preterm (LBW)	$351	$181	$197	$177	$23	$183	$47	$183	$186
Perinatal - Neonatal Respiratory Distress Syndrome	$9	$23	$18	$31	$5	$31	$3	$31	$32
Perinatal Period - Conditions Originating in Perinatal Period	$387	$413	$449	$470	$65	$542	$84	$541	$551
Pick's Disease	$1	$3	$2	$2	$0	$2	$0	$2	$2
Pneumonia	$132	$105	$93	$108	$15	$93	$17	$93	$95
Pneumonia & Influenza	$405	$382	$295	$392	$58	$396	$102	$396	$404
Polycystic Kidney Disease	$36	$33	$41	$38	$7	$35	$6	$35	$36
Prescription Drug Abuse	-	**	N/A	N/A	N/A	$29	$7	$29	$29
Prevention	$6,729	$4,596	$4,623	$5,332	$844	$5,983	$849	$5,981	$6,113
Prostate Cancer	$345	$295	$290	$310	$47	$331	$31	$331	$337
Psoriasis	$10	$22	$8	$13	$3	$13	$3	$13	$13
Regenerative Medicine	$575	$697	$723	$799	$144	$820	$142	$819	$834
Rehabilitation	$344	$379	$403	$404	$75	$458	$93	$458	$466
Rett Syndrome	$6	$6	$9	$9	$4	$13	$2	$13	$13
Reye's Syndrome	$1	$0	$0	$0	$0	$0	$0	-	-
Rural Health	$208	$173	$170	$186	$42	$207	$33	$207	$211
Schizophrenia	$358	$220	$249	$265	$85	$276	$63	$276	$282
Scleroderma	$12	$12	$20	$21	$2	$19	$2	$19	$19
Screening And Brief Intervention For Substance Abuse	-	**	N/A	N/A	N/A	$26	$4	$26	$27
Septicemia	$49	$93	$95	$92	$19	$90	$17	$90	$92
Sexually Transmitted Diseases/Herpes	$288	$282	$245	$250	$43	$250	$38	$250	$255
Sickle Cell Disease	$94	$78	$80	$63	$14	$73	$12	$73	$75
Sleep Research	$190	$219	$225	$217	$33	$226	$22	$226	$230
Small Pox	$122	$142	$94	$94	$4	$92	$5	$92	$94
Smoking and Health	$534	$324	$310	$329	$78	$336	$55	$336	$342
Spina Bifida	$9	$14	$15	$14	$3	$12	$6	$12	$12
Spinal Cord Injury	$64	$90	$80	$80	$14	$87	$16	$87	$88
Spinal Muscular Atrophy	$11	$11	$10	$11	$3	$16	$3	$16	$17
Stem Cell Research	$657	$968	$938	$1,044	$187	$1,099	$187	$1,098	$1,118
Stem Cell Research - Embryonic - Human	$42	$74	$88	$120	$23	$126	$40	$125	$128
Stem Cell Research - Embryonic - Non-Human	$106	$120	$150	$148	$29	$175	$20	$175	$178
Stem Cell Research - Nonembryonic - Human	$203	$226	$297	$339	$58	$341	$74	$341	$347
Stem Cell Research - Nonembryonic - Non-Human	$306	$400	$497	$550	$88	$570	$74	$569	$580
Stem Cell Research - Umbilical Cord Blood/ Placenta	$22	$44	$46	$49	$10	$42	$8	$42	$42
Stem Cell Research - Umbilical Cord Blood/ Placenta - Human	$19	$38	$38	$42	$9	$40	$7	$40	$40
Stem Cell Research - Umbilical Cord Blood/ Placenta - Non-Human	$2	$9	$9	$10	$1	$5	$1	$5	$5
Stroke	$340	$288	$296	$329	$54	$337	$54	$337	$343
Substance Abuse 9/	$1,523	$1,636	$1,763	$1,653	$245	$1,674	$216	$1,666	$1,697
Substance Abuse Prevention	-	**	N/A	N/A	N/A	$43	$10	$43	$44
Sudden Infant Death Syndrome	$81	$25	$29	$22	$6	$25	$2	$25	$26
Suicide	$43	$52	$39	$36	$15	$36	$4	$36	$37
Suicide Prevention	-	**	N/A	N/A	N/A	$17	$2	$17	$18
Teenage Pregnancy	$16	$24	$21	$23	$5	$22	$5	$22	$23
Temporomandibular Muscle/Joint Disorder (TMJD)	$15	$18	$19	$15	$1	$16	$1	$16	$16
Tobacco	$536	$325	$311	$331	$78	$339	$55	$339	$345
Topical Microbicides	$99	$92	$102	$92	$7	$84	$5	$84	$86
Tourette Syndrome	$11	$9	$8	$7	$3	$7	$0	$7	$7
Transmissible Spongiform Encephalopathy (TSE)	$43	$50	$44	$43	$4	$48	$3	$48	$49
Transplantation	$534	$544	$519	$571	$94	$574	$109	$574	$584
Tuberculosis	$166	$188	$142	$189	$27	$189	$35	$189	$192
Tuberculosis Vaccine	$17	$23	$18	$15	$3	$13	$3	$13	$14
Tuberous Sclerosis	$12	$20	$20	$20	$3	$20	$2	$20	$20
Underage Drinking	-	**	N/A	N/A	N/A	$75	$5	$75	$76
Underage Drinking – Prevention & Treatment (NIAAA Only) 14/	-	**	N/A	N/A	N/A	$56	$2	$55	$56
Urologic Diseases	$526	$535	$534	$578	$81	$563	$56	$562	$573
Uterine Cancer	$22	$24	$16	$25	$4	$26	$4	$26	$26
Vaccine Related	$1,358	$1,659	$1,632	$1,593	$185	$1,737	$222	$1,736	$1,771
Vaccine related (AIDS) 6/	$597	$597	$556	$561	$35	$535	$27	$535	$546
Vector-Borne Diseases	$424	$478	$417	$401	$66	$426	$68	$426	$435
Violence Against Women	$24	$49	$45	$39	$2	$36	$2	$36	$37
Violence Research	$106	$190	$183	$182	$21	$174	$19	$174	$177
Vulvodynia	-	**	+	$1	$1	$2	$1	$2	$2
West Nile Virus	$69	$81	$39	$59	$7	$46	$6	$45	$46
Women's Health 5/	$3,470	$3,470	$3,514	$3,725	$506	$3,691	$449	$3,689	$3,757
Youth Violence	$60	$123	$115	$111	$12	$102	$10	$102	$104
Youth Violence Prevention	-	**	N/A	N/A	N/A	$32	$2	$32	$33

[*]	The minimum reporting threshold for a specific disease/condition is $500,000. Reporting of $0 does not indicate that no research is being conducted.
[**]	No methodology was identified for RCDC in 2007; therefore there is no data available under the “FY 2007 Actual” column.
[+]	Indicates a new category. Funding support data not available prior to the actual FY 2009 or FY 2010 level reported.
1/	Reporting for this category does not follow the standard RCDC process. The total amount reported is consistent with reporting requirements for this category to the U.S. Office of Management & Budget (OMB). The project listing does not include non-project or other support costs associated with the annual total for this category. Additional information on this category is available at http://www.niaid.nih.gov/topics/biodefenserelated/pages/default.aspx.
2/	Includes research funded from the Type 1 diabetes appropriation of $150,000,000. These are project listings only.
3/	Reporting for this category does not follow the standard RCDC process. Spending is reported consistent with U.S. Office of National Drug Control Policy (ONDCP) requirements (Only NIDA). More information on this area is available at http://www.drugabuse.gov/drugpages/.
4/	Reported total for this category encompasses research for anorexia, bulimia nervosa, binge eating disorders, and eating disorders not otherwise specified.
5/	Reporting for this category does not follow the standard RCDC process. This category assigns project funding according to populations tracked by gender or ethnicity. The databases used to track gender/ethnicity are complex and not currently compatible with the RCDC system.
6/	Reporting for this category does not follow the standard RCDC process. These are project listings only and non-project or other support costs associated with the annual total for the category are not included. More information on this area is available at http://www.oar.nih.gov/.
7/	Reporting for this category does not follow the standard RCDC process. This category uses a non-standard approach involving subject matter expert reviews of manually collected project listings.
8/	The data provided reflects funding amounts reported by the NIH RCDC process for this category. Actual and estimate levels presented on this site supersede FY 2010-2012 amounts detailed in OMB MAX DE application tables that were based on preliminary FY 2010 funding support information.
9/	Reporting for this category does not follow the standard RCDC process. This category includes all spending reported under the Drug Abuse category as well as projects categorized under the broader area of Substance Abuse. These are project listings only. More information on this area is available at http://www.drugabuse.gov/drugpages/.
10/	To illustrate the effect of the RCDC methodology change, the table shows a side-by-side comparison of FY 2007 levels produced with the prior method (“NIH Historical Method”) compared with levels that would have resulted if the new methodology had been implemented (“NIH Revised Method”). “NIH Historical Method” figures are considered the official “Actual” for FY 2007. The “NIH Revised Method” levels provide for comparability to FY 2008 RCDC actuals.
11/	Separate columns are used to distinguish FY 2009 and FY 2010 actual support funded from American Recovery & Reinvestment Act (ARRA) accounts from projects funded by regular annual NIH appropriations.
12/	The FY 2011 column estimate does not reflect the legislative impact of funding levels provided in Public Law 111-117 and Public Law 112-10. The current estimate of HIV/AIDS funding in FY 2011 is $3,059,277,000.
13/	The FY 2011 column estimate does not reflect the legislative impact of funding levels provided in Public Law 111-117 and Public Law 112-10. The current estimate of funding in FY 2011 is $1,050,542,000.
14/	The FY 2011 column estimate does not reflect the legislative impact of funding levels provided in Public Law 111-117 and Public Law 112-10. The current estimate of funding in FY 2011 is $55,030,000.

May	AUG	Oct
	13
2010	2011	2013